GE Healthcare Ireland Limited 2026-04-15 Health serious FDA
Health · FDA · Recall #FDA-D-0448-2026
GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by:… Recall
Issued April 15, 2026 · GE Healthcare Ireland Limited
In April 2026, GE Healthcare Ireland Limited recalled the GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by:…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Presence of particulate matter
What you should do
- 1 Stop using GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by:… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact GE Healthcare Ireland Limited to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- GE Healthcare Ireland Limited
- Category
- Health
- Recall date
- April 15, 2026
- Units affected
- Not reported
- Sold at
- U.S. Nationwide.
- Recall number
- FDA-D-0448-2026
- Made in
- Ireland
- Issuing agency
- FDA
In context
- GE Healthcare Ireland Limited has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.